Skip to main content

Advertisement

SpringerLink
Log in

Growing Old with HIV

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

The intersection of chronic HIV infection, its treatment, and lifestyle with aging has become a topic of considerable fascination during this, the third decade of the AIDS epidemic. An understanding of the pathophysiology of this intersection may provide valuable insights into our general understanding of human aging. This review summarizes the results of recent publications that may have considerable impact on screening and management strategies in the aging HIV-infected population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lohse N, Hansen AE, Pedersen G, et al.: Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med 2007; 146: 87–95.

    PubMed  Google Scholar 

  2. United States Senate Special Committee on Aging. HIV Over Fifty: Exploring the New Threat. Available at http://aging.senate.gov/hearing_detail.cfm?id=270655. Accessed October 2010.

  3. Centers for Disease Control and Prevention: HIV Surveillance Report, 2008. Available at http://www.cdc.gov/hiv/topics/surveillance. Accessed October 2010.

  4. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372: 293–299.

    Article  Google Scholar 

  5. CASCADE Collaboration. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003; 362: 1267–1274.

    Article  Google Scholar 

  6. Althoff KN, Justice AC, Gange SJ, et al.: Virologic and immunologic response to HAART, by age and regimen class. AIDS 2010; 24:2469–2479.

    Article  PubMed  Google Scholar 

  7. Hinkin CH, Hardy DJ, Mason KI, et al.: Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 2004; 18:19–25.

    Article  Google Scholar 

  8. • Deeks SG, Phillips AN: HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009; 338: a3172. A concise paper outlining the authors’ conceptual model of accelerated aging in HIV-infected persons.

  9. Appay V, Rowland-Jones SL: Premature ageing of the immune system: the cause of AIDS? TRENDS in Immunology 2002; 23:580–585.

    Article  CAS  PubMed  Google Scholar 

  10. Cao W, Jamieson BD, Hultin LE, et al.: Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr 2009;50:137–147.

    Article  PubMed  Google Scholar 

  11. Brenchley JM, Price DA, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365–1371.

    Article  CAS  PubMed  Google Scholar 

  12. Appay V, Sauce D: Immune activation and inflammation in HIV-1 infection: Causes and consequences. J Pathol 2008;214:231–241

    Article  CAS  PubMed  Google Scholar 

  13. Kuller LH, Tracy R, Belloso W, et al.: Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5:e203

    Article  PubMed  Google Scholar 

  14. Neuhaus J, Jacobs DR, Jr., Baker JV, et al.: Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection. Journal of Infectious Diseases 2010; 201:1788–1795.

    Article  CAS  PubMed  Google Scholar 

  15. Hunt PW, Brenchley J, Sinclair E, et al.: Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008; 197:126–33.

    Article  PubMed  Google Scholar 

  16. Hsue PY, Hunt PW, Schnell A, et al.: Role of Viral Replication, Antiretroviral Therapy, and Immunodeficiency in HIV- Associated Atherosclerosis. AIDS 2009; 23:1059–1067.

    Article  CAS  PubMed  Google Scholar 

  17. Grunfeld C, Delaney J, Wanke C, et al.: Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 2009; 23: 1841–1849.

    Article  PubMed  Google Scholar 

  18. Currier JS, Lundgren JD, Carr A, et al.: Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 2008, 118:e29–35.

    Article  CAS  PubMed  Google Scholar 

  19. Klein D, Hurley L, Quesenberry CB, et al.: Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? JAIDS 2002, 30:471–477.

    CAS  PubMed  Google Scholar 

  20. Micheletti RG, Fishbein GA, Fishbein MC, et al.: Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study. Cardiovasc Pathol 2008, 17:1117–1123.

    Google Scholar 

  21. •• Giovanni G, Stefano Z, Alexopoulos N, et al.: Coronary aging in HIV-infected patients. Clin Infect Dis 2009; 49:1756–62. This paper brings home the concept that the HIV heart is 10 to 15 years older than its “owner.”

  22. Hansson GK: Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med 2005; 352:1685–1695.

    Article  CAS  PubMed  Google Scholar 

  23. Carr A, Cooper DA: Adverse effects of antiretroviral therapy. Lancet 2000; 356:1423–30.

    Article  CAS  PubMed  Google Scholar 

  24. Friis-Møller N, Reiss P, Sabin CA, et al. for the D:A:D study group: Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007, 356:1723–1735.

    Article  PubMed  Google Scholar 

  25. • D:A:D Study Group: Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008, B:1417–1425. These observations on the interplay of abacavir therapy and myocardial infarction created a storm that reverberates to this day.

  26. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group: CD4+ Count–Guided Interruption of Antiretroviral Treatment. New Engl J Med 2006; 355:2283–2296

    Article  Google Scholar 

  27. Tebas P, Henry WK, Matining R, et al.: Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. PLoS ONE 2008; 3: e2021.

    Article  PubMed  Google Scholar 

  28. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C: Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000; 181(Suppl 3):S462–72.

    Article  CAS  PubMed  Google Scholar 

  29. Dubé MP, Lipshultz SE, Fichtenbaum CJ, et al.: Working Group 3: Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation 2008, 118:e36–e40.

    Article  PubMed  Google Scholar 

  30. D:A:D Study Group: Association between Modifiable and Non-modifiable Risk Factors and Specific Causes of Death in the HAART Era: The Data Collection on Adverse Events of Anti-HIV Drugs Study. 16th Conference on Retroviruses and Opportunistic Infections. 2-12-2009; Montreal, Canada. Abstract 145.

  31. Bloom FE, Rausch DM: HIV in the brain: Pathology and neurobehavioral consequences. Journal of Neurovirology. 1997; 3:102–109.

    Article  CAS  PubMed  Google Scholar 

  32. Antinori A, Arendt G, Becker JT, et al.: Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 2007; 69:1789–1799

    Article  CAS  PubMed  Google Scholar 

  33. Chauhan A, Turchan J, Pocernich C, et al.: Intracellular human immunodeficiency virus tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biolog Chem 2003, 278:13512–13519.

    Article  CAS  Google Scholar 

  34. Gonzalez E, Rovin BH, Sen L, et al.: HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. PNAS 2002; 99:13795–13800.

    Article  CAS  PubMed  Google Scholar 

  35. Sacktor N, Skolasky R, Selnes OA, et al.: Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol 2007; 13:203–209.

    Article  PubMed  Google Scholar 

  36. Hardy DJ, Hinkin CH, Satz P, et al.: Age differences and neurocognitive performance in HIV-infected adults. New Zealand J Psychol 1999; 28:94–101.

    Google Scholar 

  37. Valcour V, Shikuma CM, Shiramizu BT, et al.: Diabetes, insulin resistance, and dementia among HIV-1-infected patients. J Acquir Immune Defic Syndr 2005; 38:31–36.

    Article  PubMed  Google Scholar 

  38. •• Ances BM, Vaida F, Yeh MJ, et al.: HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis 2009; 201:336–340. A striking finding that shows the cerebral blood flow in the HIV-infected brain is comparable to that seen in an uninfected brain 10 to 15 years older.

  39. Esiri MM, Biddolph SC, Morris CS: Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 1998; 65:29–33.

    Article  CAS  PubMed  Google Scholar 

  40. Kallianpur K, McMurtray A, Valcour V, et al.: Abstract #460: Reduced region-specific corpus collosum volumes correlate with low nadir CD4 and decreased cognition in HIV-infected carriers of the Apo E4 allele. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; February 2009; Montreal, CA.

  41. Letendre SL, Marquie-Beck J, Capparelli E, et al.: Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008; 65:65–70.

    Article  PubMed  Google Scholar 

  42. Letendre SL, McCutchan JA, Childers ME, et al.: Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 2004; 56:416–423.

    Article  PubMed  Google Scholar 

  43. Marra CM, Zhao Y, Clifford DB, et al: Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 2009 Jul 17; 23(11):1359–66.

    Article  PubMed  Google Scholar 

  44. Aukrust P, Huag CJ, Ueland T, et al.: Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab 1999; 84 145–150.

    Article  CAS  PubMed  Google Scholar 

  45. •• Brown TT, Qaqish RB: Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20:2165–2174. These observations made a change in how I care for older HIV-infected patients.

  46. Dao C, Young B, Buchacz K, et al.: Abstract 128. Higher and Increasing Rates of Fracture Among HIV-infected Persons in the HIV Outpatient Study Compared to the General US Population, 1994 to 2008. 17th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA; February 16–19, 2010.

  47. Grulich AE, van Leeuwen MT, Falster MO, et al.: Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370:59–67.

    Article  PubMed  Google Scholar 

  48. Smit C, Geskus R, Walker S, et al.: Effective therapy has altered the spectrum of cause specific mortality following HIV seroconversion. AIDS 2006; 20:741–749.

    Article  PubMed  Google Scholar 

  49. Sackoff JE, Hanna DP, Pfeiffer MR, et al.: Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006:145:397–406.

    PubMed  Google Scholar 

  50. Effros RB, Fletcher CV, Gebo K, et al.: Aging and infectious diseases: Workshop on HIV infection and aging; what is known in future research directions. Clinic Infect Dis 2008; 47:542–553.

    Article  Google Scholar 

  51. • Shiels MS, Pfeiffer RM, Engels EA: Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 2010; 153:452-460. An important paper that removes non–AIDS-defining malignancies from the pantheon of “diseases of accelerated aging in HIV.” Excellent accompanying editorial.

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Infectious Diseases, Wayne State University School of Medicine, c/o Harper University Hospital, 3990 John R Street, Room 2922 Hudson, Detroit, MI, 48201, USA

    Lawrence R. Crane

  2. Department of Medicine, Division of Infectious Diseases, Wayne State University School of Medicine, c/o Harper University Hospital, 3990 John R Street, Room 5929 Hudson, Detroit, MI, 48201, USA

    Diixa Patel

Authors
  1. Diixa Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence R. Crane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lawrence R. Crane.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, D., Crane, L.R. Growing Old with HIV. Curr Infect Dis Rep 13, 75–82 (2011). https://doi.org/10.1007/s11908-010-0146-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-010-0146-8

Keywords

Search

Navigation